Schizophrenia Research
Volume 49, Issue 3 , Pages 269-285 , 30 April 2001

How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment

Received 10 February 2000 ,Accepted 25 April 2000.

References 

  1. Abrams R, Taylor MA, Coleman KA. Catatonia and mania: patterns of cerebral dysfunction. Biol. Psychiatry. 1979;14:111–117
  2. Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophr. Res. 1991;5:51–59
  3. Addington J, Addington D, Maticka-Tyndale E. Reliability and validity of a depression rating scale for schizophrenia. Schizophr. Res. 1992;6:201–208
  4. Andreasen NC, Olsen S. Negative v. positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry. 1982;39:789–794
  5. Andreasen NC, Flaum M, Alliger R, Swayze VW. Positive and negative symptoms: assessment and validity. In:  Marneros A, et al. editor. Negative Versus Positive Schizophrenia. Berlin: Springer; 1991;
  6. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 1995;52:341–351
  7. Arndt, S., Andreason, N.C., Flaum, M., Miller, D., Nopoulos, P., 1995. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch. Gen. Psychiatry 52, 352–360.
  8. Bell RC, Low LH, Jackson HJ, Dudgeon PL, Copolov DL, Singh DS. Latent trait modeling of symptoms of schizophrenia. Psychol. Med. 1994;24:335–345
  9. Berrios GE, Chen EIH. Recognising psychiatric symptoms. Relevance to the diagnostic process. Br. J. Psychiatry. 1993;163:308–314
  10. Bilder RM, Mukhergee S, Rieder RO. Symptomatic and neuropsychological components of defect state. Schizophr. Bull. 1985;11:409–419
  11. Brekke JS, DeBonis JA, Graham JW. A latent structure analysis of the positive and negative symptoms in schizophrenia. Compr. Psychiatry. 1994;35:252–259
  12. Cardno AG, Jones LA, Murphy KC, Asherson P, Scott LC, Williams J, et al. Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophr. Res. 1996;22:233–239
  13. Carpenter WT, Buchanan RW. Domains of psychopathology relevant to the study of etiology and treatment in schizophrenia. In:  Schulz SC,  Tamminga CA editor. Schizophrenia: Scientific Progress. New York: Oxford University Press; 1989;p. 13–22
  14. Carpenter WT, Heinrichs DW, Wagman DW. Deficit and non-deficit forms of schizophrenia: the concept. Am. J. Psychiatry. 1988;145:578–583
  15. Crow TJ. Molecular pathology of schizophrenia: more than one disease process. Br. Med. J. 1980;280:66–68
  16. Cuesta MJ, Peralta V. Lack of insight in schizophrenia. Schizophr. Bull. 1994;20:359–366
  17. Cuesta MJ, Peralta V. Thought disorder in schizophrenia. Testing models through confirmatory factor analysis. Eur. Arch. Psychiatr. Clin. Neurosci. 1999;249:55–61
  18. Cuesta, M.J., Peralta, V. Psychopathological dimensions in major psychoses: a hierarchical approach. Submitted.
  19. Czobor P, Volavka J. Dimensions of the brief psychiatric rating scale: an examination of stability during haloperidol treatment. Compr. Psychiatry. 1996;37:205–215
  20. Dollfus S, Everitt B. Symptom structure in schizophrenia: two-, three-, or four-factors models. Psychopathology. 1998;31:120–130
  21. Dollfus S, Petit M. Principal-component-analyses of PANSS and SANS-SAPS in schizophrenia. Their stability in an acute phase. Eur. Psychiatry. 1995;10:97–106
  22. Dollfus S, Petit M. Stability of positive and negative symptoms in schizophrenic patients: a three-year follow-up. Eur. Psychiatry. 1995;10:228–236
  23. Eaton, W.W., Thara, R., Federman, B., Malton, B., Liang, K., 1995. Structure and course of positive and negative symptoms in schizophrenia. Arch. Gen. Psychiatry 52, 127–134.
  24. Flaum M, O'Leary DS, Swaize II VW, Miller DD, Arndt S, Andreasen NC. Symptom dimensions and brain morphology in schizophrenia and related disorders. J. Psychiatr. Res. 1995;29:261–276
  25. Goldman RS, Tandon R, Liberzon I, Goodson J, Greden JF. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia. Psychopathology. 1991;24:247–252
  26. Grube, B.S., Bilder, R.M., Goldman, R.S., 1998. Meta-analysis of symptom factors in schizophrenia, Schizophr. Res. 31, 113–120.
  27. Gureje O, Aderibigbe YA, Obikoya O. Three syndromes in schizophrenia: validity in young patients with recent onset illness. Psychol. Med. 1995;25:715–725
  28. Harvey CA, Curson DA, Pantelis C, Taylor J, Barnes TRE. Four behavioural syndromes of schizophrenia. Br. J. Psychiatry. 1996;168:562–570
  29. Harvey PD, Davidson M, White L, Keefe RSE, Hirschowitz J, Mohs RC, et al. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the Brief Psychiatric Rating Scale. Biol. Psychiatry. 1996;40:755–760
  30. Hori A, Tsunashima K, Watanabe K, Takekawa Y, Ishihara I, Terada A, et al. Symptom classification of schizophrenia changes with the duration of illness. Acta Psychiatr. Scand. 1999;99:447–452
  31. Hutchinson G, Takei N, Sham P, Harvey I, Murray RM. Factor analysis of symptoms in schizophrenia: differences in White and Caribbean patients in Camberwell. Psychol. Med. 1999;29:607–612
  32. Jackson, H.J., Burgess, P.M., Minas, I.H., Joshua, S.D., 1990. Psychomatric properties of the Manchester scale. Acta Phsychiatr. Scand. 81, 108–113.
  33. Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol. Med. 1996;1996(26):669–679
  34. Kitamura T, Okazaki Y, Fujinawa A, Yoshino M, Kasahara Y. Symptoms of psychoses. A factor-analytic study. Br. J. Psychiatry. 1995;166:236–240
  35. Klimidis S, Stuart GW, Minas IH, Copolov DL, Singh BS. Positive and negative symptoms in the psychoses. Re-analysis of published SAPS and SANS global ratings. Schizophr. Res. 1993;9:11–18
  36. Kulhara K, Chandiramani K. Positive and negative subtypes of schizophrenia: a follow-up study from India. Schizophr. Res. 1990;3:107–116
  37. Lenzenweger MF, Dworkin RH. The dimensions of schizophrenic phenomenology? Not one or not two, at least three, perhaps four. Br. J. Psychiatry. 1996;168:432–440
  38. Liddle PF. The symptoms of chronic schizophrenia: a re-examination of the positive–negative dichotomy. Br. J. Psychiatry. 1987;151:145–151
  39. Liddle PF, Barnes TRE. The subjective experience of deficits in schizophrenia. Compr. Psychiatry. 1988;29:157–164
  40. Lin ASK, Chen CH, Hwu HG, Lin HN, Chen JA. Psychopathological dimensions in schizophrenia: a correlational approach to the items of SANS and SAPS. Schizophr. Res. 1998;77:121–130
  41. Lorr ML, McNair DM, Klett CJ, Lasky JJ. Evidence of ten psychotic syndromes. J. Consult. Psychol. 1962;26:185–189
  42. Malla AK, Norman RMG, Williamson P, Cortese L, Diaz F. The syndrome concept of schizophrenia. A factor analytic study. Schizophr. Res. 1993;10:143–150
  43. Marková IS, Berrios GE. The assessment of insight in clinical psychiatry: a new scale. Acta Psychiatr. Scand. 1992;86:159–164
  44. Maziade M, Roy A, Martinez M, Cliche D, Fournier JP, Garneau Y, et al. Negative, psychoticism and negative dimensions in patients with schizophrenia or bipolar disorder: continuity and discontinuity between the major psychosis. Am. J. Psychiatry. 1995;152:1458–1463
  45. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol. Med. 1998;28:935–947
  46. Mellers JDC, Sham P, Jones PB, Toone BK, Murray RM. A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatr. Scand. 1996;93:92–98
  47. Mellor CS. Methodological problems in identifying and measuring first-rank symptoms of schizophrenia. In:  Marneros A, et al. editor. Negative Versus Positive Schizophrenia. Berlin: Springer; 1991;
  48. Minas IH, Klimidis S, Stuart GW, Copolov DL, Singh BS. Positive and negative symptoms in the psychoses: principal components analysis of items from the scale for the assessment of positive symptoms and the scale for the assessment of negative symptoms. Compr. Psychiatry. 1994;35:135–144
  49. Minas IH, Stuart GW, Klimidis S, Jackson HJ, Singh BS, Copolov DL. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items. Schizophr. Res. 1992;8:143–156
  50. Mojtabai, R., 1999. Duration of illness and structure of symptoms in schizophrenia. Psychol. Med. 29, 915–924.
  51. Müller MJ, Wetzel H, Szegedi A, Benkert O. Three dimensions of depression in patients with acute psychotic disorders: a replication study. Compr. Psychiatry. 1999;40:449–457
  52. Murphy BM, Burke JG, Bray JC, Walsh D, Kendler KS. An analysis of the clinical features of familial schizophrenia. Acta Psychiatr. Scand. 1994;89:421–427
  53. Nakaya M, Suwa H, Ohmori K. Latent structures underlying schizophrenic symptoms: a five dimensional model. Schizophr. Res. 1999;39:39–50
  54. Nakaya M, Suwa H, Komahashi T, Ohmori K. Is schizophrenic symptomatology independent of the phase of the illness?. Psychopathology. 1999;32:23–29
  55. Overall JE, Klett CJ. Applied Multivariate Analysis. New York: McGraw Hill; 1972;
  56. Overall, J.E., Woodward, J.A., 1975. Conceptual validity of a phenomenological classification of psychiatric patients, J. Psychiatr. Res. 12, 215–230.
  57. Peralta V, Cuesta MJ. Subjective experiences in schizophrenia: a critical review. Compr. Psychiatry. 1994;35:198–204
  58. Peralta V, Cuesta MJ. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. Am. J. Psychiatry. 1995;152:1450–1457
  59. Peralta V, Cuesta MJ. Factor structure and clinical validity of competing models of positive symptoms in schizophrenia. Biol. Psychiatry. 1998;44:107–114
  60. Peralta V, Cuesta MJ. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr. Res. 1999;38:13–26
  61. Peralta V, Cuesta MJ. Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr. Res. 1999;40:245–253
  62. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr. Res. 2000;in press
  63. Peralta, V., Cuesta, M.J., 2000. Duration of illness and structure of symptoms in schizophrenia. Psychol. Med. 30, 481–483.
  64. Peralta V, Cuesta MJ, de Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol. Psychiatry. 1994;36:726–736
  65. Peralta V, Cuesta MJ, Farre C. Factor structure of symptoms in functional psychoses. Biol. Psychiatry. 1997;42:806–815
  66. Ratakonda S, Gorman JM, Yale SA, Amador XF. Characterization of psychotic conditions. Use of the domains of psychopathology model. Arch. Gen. Psychiatry. 1998;55:75–81
  67. Ray, E.-R., Bräuer, W., Händel, M., Laubenstein, D., Stein, A., 1994. Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiatr. Scand. 90, 405–412.
  68. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion of hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 1997;349:1735–1739
  69. Salokangas RKR. Structure of schizophrenic symptomatology and its change over time: prospective factor-analytical study. Acta Psychiatr. Scand. 1997;95:32–39
  70. Schuldberg D, Quinlan DM, Morgenstern H, Glazer W. Positive and negative symptoms in chronic psychiatric outpatients: reliability, stability and factor structure. J. Consult. Clin. Psychol. 1990;3:262–268
  71. Serretti A, Macciardi F, Smeraldi E. Identification of symptomatological patterns common to major psychoses: proposals for a phenotype definition. Am. J. Med. Gen. 1996;67:393–400
  72. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Cannon T, Gur RC. Phenomenology and functioning in first-episode schizophrenia. Schizophr. Bull. 1992;18:449–462
  73. Silver H, David D, Kaplan M, Hadjez J, Tubi N, Darnel A, et al. Factor analysis of schizophrenic symptoms and comparison of different ratings scales. Schizophr. Res. 1993;10:67–75
  74. Smith DA, Mar CM, Turoff BK. The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis. Schizophr. Res. 1998;31:57–70
  75. Stuart GW, Pantelis C, Klimidis S, Minas IH. The three-syndrome model of schizophrenia. Meta-analysis of an artefact. Schizophr. Res. 1999;39:233–242
  76. Thomson PA, Meltzer HY. Positive, negative, and disorganization factors from the Schedule for Affective Disorders and Schizophrenia and the Present State Examination. Br. J. Psychiatry. 1993;163:344–351
  77. Toomey R, Kremen WS, Simpson JC, Samson JA, Seidman LJ, Lyons MJ, et al. Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am. J. Psychiatry. 1997;154:371–377
  78. Van der Does AJW, Dingemans PMAJ, Linszen DH, Nugter MA, Scholte WF. Dimensions and subtypes of recent onset schizophrenia. A longitudinal analysis. J. Nerv. Ment. Dis. 1995;183:681–687
  79. Van Os J, Jones FP, Harvey I, Sham P, Lewis S, Bebbington P, et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol. Med. 1996;26:161–176
  80. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, et al. A comparison of the utility of dimensional and categorical representations of psychosis. Psychol. Med. 1999;29:595–606
  81. Vazquez-Barquero JL, Lastra I, Cuesta Nuñez MJ, Herrera Castañedo S, Dunn G. Patterns of positive and negative symptoms in first episode schizophrenia. Br. J. Psychiatry. 1996;168:693–701
  82. White L, Harvey PD, Opler L, Lindenmayer D  PANSS study group. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology. 1997;30:263–274

PII: S0920-9964(00)00071-2

Schizophrenia Research
Volume 49, Issue 3 , Pages 269-285 , 30 April 2001

Article Tools